Published in Am J Respir Cell Mol Biol on January 24, 2008
Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci Signal (2008) 2.33
Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides. Chem Biol (2009) 1.18
Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease. J Amino Acids (2011) 1.12
Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells. PLoS Pathog (2010) 1.04
Attachment of Chlamydia trachomatis L2 to host cells requires sulfation. Proc Natl Acad Sci U S A (2012) 1.00
Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120. Biochemistry (2009) 0.95
Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1). J Biol Chem (2013) 0.92
Position weight matrix, gibbs sampler, and the associated significance tests in motif characterization and prediction. Scientifica (Cairo) (2012) 0.92
Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus. J Biol Chem (2009) 0.89
Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering. Curr Biotechnol (2012) 0.86
Sulfotyrosine recognition as marker for druggable sites in the extracellular space. Int J Mol Sci (2011) 0.85
Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery. ACS Chem Biol (2013) 0.85
Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction. Curr Top Med Chem (2012) 0.82
Sulfated tyrosines 27 and 29 in the N-terminus of human CXCR3 participate in binding native IP-10. Acta Pharmacol Sin (2009) 0.79
Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus. Acta Pharmacol Sin (2011) 0.78
Predicting sulfotyrosine sites using the random forest algorithm with significantly improved prediction accuracy. BMC Bioinformatics (2009) 0.76
Structural Analysis of Chemokine Receptor-Ligand Interactions. J Med Chem (2017) 0.75
NMR in the Analysis of Functional Chemokine Interactions and Drug Discovery. Drug Discov Today Technol (2012) 0.75
A Multifeatures Fusion and Discrete Firefly Optimization Method for Prediction of Protein Tyrosine Sulfation Residues. Biomed Res Int (2016) 0.75
Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer. Oncotarget (2016) 0.75
Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands. Int J Mol Sci (2017) 0.75
ProbCons: Probabilistic consistency-based multiple sequence alignment. Genome Res (2005) 11.90
The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med (2006) 10.99
International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev (2000) 7.17
Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc Natl Acad Sci U S A (2004) 5.15
Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell (1999) 4.97
M-Coffee: combining multiple sequence alignment methods with T-Coffee. Nucleic Acids Res (2006) 4.53
Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol (2007) 3.43
Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol (2002) 3.38
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell (2003) 3.03
The biology and enzymology of protein tyrosine O-sulfation. J Biol Chem (2003) 2.80
Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J Virol (1999) 2.24
Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J Biol Chem (2000) 2.07
Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry (1999) 1.96
The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med (2005) 1.95
The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry. J Biol Chem (2002) 1.66
Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12). J Mol Biol (2006) 1.63
The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J Biol Chem (1996) 1.58
Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med (2005) 1.52
Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure (1999) 1.47
The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J Biol Chem (2002) 1.46
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Mol Cell Biol (2006) 1.42
Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry (1999) 1.40
Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J Exp Med (2001) 1.39
Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J Biol Chem (1999) 1.36
Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region. J Immunol (2000) 1.35
CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J Biol Chem (2002) 1.30
A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol (2006) 1.23
A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection. J Biol Chem (2006) 1.23
CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. Proc Natl Acad Sci U S A (1998) 1.15
A mutation in Tpst2 encoding tyrosylprotein sulfotransferase causes dwarfism associated with hypothyroidism. Mol Endocrinol (2007) 1.04
Determination of the sites of tyrosine O-sulfation in peptides and proteins. Nat Methods (2007) 1.03
CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor. J Biol Chem (2004) 1.01
Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax (2006) 1.01
Analysis of post-translational CCR8 modifications and their influence on receptor activity. J Biol Chem (2004) 0.99
Characterization of binding between the chemokine eotaxin and peptides derived from the chemokine receptor CCR3. J Biol Chem (2000) 0.98
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy (2004) 0.97
Differential enzymatic characteristics and tissue-specific expression of human TPST-1 and TPST-2. J Biochem (2006) 0.97
Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J Immunol (2000) 0.95
The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation. J Biol Chem (1998) 0.94
Chemokines and their receptors in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med (2003) 0.94
Drugs for asthma. Br J Pharmacol (2006) 0.94
Tyrosine O-sulfation promotes proteolytic processing of progastrin. EMBO J (1995) 0.86
Reevaluation of the determinants of tyrosine sulfation. Endocrine (1999) 0.83
Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun (2008) 1.57
The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly. J Allergy (Cairo) (2011) 1.49
Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res (2003) 1.28
Molecular recognition of aldehydes by aldehyde dehydrogenase and mechanism of nucleophile activation. Proteins (2004) 1.03
Cutting edge issues in Goodpasture's disease. Clin Rev Allergy Immunol (2011) 1.02
The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis. J Am Geriatr Soc (2010) 0.98
The Class D beta-lactamase family: residues governing the maintenance and diversity of function. Protein Eng Des Sel (2011) 0.90
Integrating palliative care in severe chronic obstructive lung disease. COPD (2008) 0.89
Definition of critical asthma syndromes. Clin Rev Allergy Immunol (2015) 0.82
MPI-PHYLIP: parallelizing computationally intensive phylogenetic analysis routines for the analysis of large protein families. PLoS One (2010) 0.81
Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis. Hepatol Res (2008) 0.81
An algorithm for identification and ranking of family-specific residues, applied to the ALDH3 family. Chem Biol Interact (2003) 0.81
Therapeutic update in idiopathic pulmonary fibrosis. Clin Rev Allergy Immunol (2013) 0.80
Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun (2009) 0.80
Initial catalytic events in class 3 aldehyde dehydrogenase: MM and QM/MM simulations. Chem Biol Interact (2003) 0.80
Autoimmunity and tyrosine sulfation. Autoimmun Rev (2005) 0.80
The pharmacological approach to the elderly COPD patient. Drugs Aging (2013) 0.79
Prediction of tyrosine sulfation in seven-transmembrane peptide receptors. Endocrine (2002) 0.78
Prediction of tyrosine sulfation sites in animal viruses. Biochem Biophys Res Commun (2003) 0.78
Difficult-to-control asthma in adults. Am J Med (2007) 0.78
Mathematically complete nucleotide and protein sequence searching using Ssearch. Curr Protoc Bioinformatics (2004) 0.77
The adult asthmatic. Clin Rev Allergy Immunol (2012) 0.76
Critical asthma syndrome in the ICU. Clin Rev Allergy Immunol (2015) 0.76
Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease. Pulm Med (2011) 0.75
Re: Watts et al. Proteins 2002;48:161-168. Proteins (2003) 0.75
Severe chronic obstructive pulmonary disease. Clin Rev Allergy Immunol (2003) 0.75
Severe obstructive airway disorders and diseases: vocal fold dysfunction. Clin Rev Allergy Immunol (2003) 0.75
Crucial role of position 40 for interactions of CCK-58 revealed by sequence of cat CCK-58. Biochem Biophys Res Commun (2006) 0.75